Veit L Buecklein

33PUBLICATIONS
257CO-AUTHORS
HaematologyHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Medical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (33)

|Aug 31, 2026
Tisagenlecleucel for post-transplant relapse in young acute lymphoblastic leukemia patients: European real-world determinants of outcome.

|Aug 24, 2026
TP53-mutant CHIP defines a pro-inflammatory phenotype and predicts adverse outcomes after CAR T-cell therapy.

|Jun 01, 2026
TP53 deficiency in AML induces resistance to T-cell engagers through an immunosuppressive secretome.

|Mar 13, 2026
IDH2 clonal hematopoiesis and IKAROS loss cooperate in a B-ALL subtype after lenalidomide therapy for multiple myeloma.

Johanna M Horns, Thomas Beder, Axel Künstner

|Jan 05, 2026
Time of day of CAR T-cell infusion and outcomes in large B-cell lymphoma.

Danny Luan, Ori Ben Valid, Ofrat Beyar-Katz

|Dec 15, 2025
2025 update on MRD in acute myeloid leukemia: a consensus document from the ELN-DAVID MRD Working Party.

Jacqueline Cloos, Peter J M Valk, Christian Thiede

Pageof 6

Frequent Collaborators

22 joint publications

Marion Subklewe

12 joint publications

Marion Subklewe

7 joint publications

Daniel Nixdorf

7 joint publications

Nora Philipp